A PwC partner who the ATO claims was assigned to work on a matter for meat processing company JBS to bring a “cloak of legal privilege” kept a supporting role on the brief despite the company CFO’s dissatisfaction, a court has heard.
Merck Sharp & Dohme is seeking to overturn a judgment refusing an extension of a patent covering its Januvia and Janumet diabetes drugs that would have seen the US drug maker of retaining a monopoly over the multibillion dollar medicines beyond July 2022.
A PwC partner who the ATO claims was assigned to work on a matter for meat processing company JBS to bring a “cloak of legal privilege” earned hundreds of dollars less per hour than his non-lawyer assistants, a court has heard.
Meat processing company and former PricewaterhouseCoopers client JBS has slammed as a “nightmare to the rule of law” a claim by the Commissioner of Taxation that the accounting giant’s internal protocols destroyed the company’s lawyer-client relationship.
Accounting giant PricewaterhouseCoopers used one of its legally qualified partners as a “postbox” to provide a “cloak of privilege” to work conducted for meat processing company JBS, the Commissioner of Taxation has told the Federal Court.
A judge has thrown out an urgent bid by Australian religious leaders for a temporary exemption from COVID-19 lockdown orders in NSW and Victoria to observe upcoming religious holidays, saying granting the injunction may lead to deaths.
BlueScope Steel general manager Jason Ellis wanted no record kept of a meeting with four of the company’s competing steel distributors and warned his national sales manager to keep the talks under wraps, a court hearing the ACCC’s price-fixing case was told on Thursday.
A judge has ordered the ACCC to pay the State of NSW’s costs in its failed proceeding against NSW Ports, finding that even though the consumer watchdog did not initially sue the state government that it was a “necessary and proper” party to the case.
Tens of thousands of hospital patients were put at risk when Medtronic unlawfully supplied a bone grafting kit to hospitals that was not registered on the Australian Register of Therapeutic Goods, according to new regulatory proceedings.
BlueScope has labelled “delusional” an argument by the competition regulator that alleged correspondence from a distributor about the steel company’s suggested higher prices was evidence of price-fixing.